guhong

10/01/2023 - "Targeted Energy Metabolomics Combined with Spatial Metabolomics Study on the Efficacy of Guhong Injection Against Cerebral Ischemia Reperfusion."
01/01/2021 - "Guhong Injection Protects Against Apoptosis in Cerebral Ischemia by Maintaining Cerebral Microvasculature and Mitochondrial Integrity Through the PI3K/AKT Pathway."
05/01/2018 - "[Pharmacokinetics of main activ ingredients of Guhong injection in cerebral ischemia rats]."
01/01/2018 - "Pharmacokinetics of Active Components From Guhong Injection in Normal and Pathological Rat Models of Cerebral Ischemia: A Comparative Study."
11/15/2023 - "A comparative study of the protective effects of Guhong injection and its component on cerebral ischemia-reperfusion injury based on the oxidation index."

07/26/2022 - "To assess the safety and efficacy of Guhong injection for mild ischemic stroke (IS). "
01/01/2023 - "This article represents a comprehensive and systematic review of existing studies on GuHong injection, including chemical composition, pharmacological mechanism, and pharmacokinetics, which provides reference significance for the clinical treatment of ischemic stroke with GuHong, as well as provides guidance for further study."
01/01/2023 - "Chemical composition, pharmacology and pharmacokinetic studies of GuHong injection in the treatment of ischemic stroke."
01/01/2023 - "As a combination of Chinese herb and chemical drug, GuHong injection has great value in drug research and clinical treatment, especially for ischemic stroke disease. "
01/01/2023 - "Pharmacological investigations have indicated that GuHong acts in the early and recovery stages of ischemic stroke by anti-inflammatory, anti-oxidative stress, anti-coagulation, neuroprotective and anti-apoptotic mechanisms simultaneously. "

11/15/2023 - "A comparative study of the protective effects of Guhong injection and its component on cerebral ischemia-reperfusion injury based on the oxidation index."
01/01/2023 - "Guhong injection mitigates myocardial ischemia/reperfusion injury by activating GST P to inhibit ASK1-JNK/p38 pathway."
01/01/2021 - "Guhong Injection Alleviates Cerebral Ischemia-Reperfusion Injury via the PKC/HIF-1α Pathway in Rats."
05/01/2018 - "To investigate the pharmacokinetic characteristics of active constituents of Guhong injection in rats with cerebral ischemia reperfusion injury. "
05/01/2017 - "Guhong injection protects against focal cerebral ischemia-reperfusion injury via anti-inflammatory effects in rats."

05/01/2018 - "The middle cerebral artery occlusion (MCAO) model was established in our studies, and then all the rats received iv administration of Guhong injection (2.1 mL·kg⁻¹). "
01/01/2022 - "In this study, the neuroprotective effect of Guhong injection (GHI) on middle cerebral artery occlusion (MCAO)-induced reperfusion injury was assessed and the mechanism was explored by RNA-seq technology. "

01/01/2023 - "The objective of this review is to comprehensively summarize the most recent information related to GuHong in the treatment of stroke, including chemical composition, clinical studies, potential pharmacological mechanisms and pharmacokinetics. "
11/01/2022 - "Discovery of anti-stroke active substances in Guhong injection based on multi-phenotypic screening of zebrafish."
01/01/2018 - "Background and Objectives: Guhong Injection (GHI) is usually administered for the treatment of stroke in clinics. "
05/01/2022 - "Guhong injection promotes post-stroke functional recovery via attenuating cortical inflammation and apoptosis in subacute stage of ischemic stroke."
05/01/2022 - "Guhong injection (GHI), consisting of safflower aqueous extract and aceglutamide, has been widely applied for the clinical treatment of cerebrovascular diseases, especially ischemic stroke and post-stroke recovery, in China. "